BUPROPION for Psoriasis: Side Effects & Safety Data
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
There are 61 adverse event reports in the FDA FAERS database where BUPROPION was used for Psoriasis.
Most Reported Side Effects for BUPROPION
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Completed suicide | 5,095 | 14.3% | 5,078 | 1,750 |
| Drug ineffective | 3,991 | 11.2% | 157 | 522 |
| Toxicity to various agents | 3,837 | 10.8% | 2,577 | 1,828 |
| Depression | 2,486 | 7.0% | 163 | 374 |
| Overdose | 2,357 | 6.6% | 584 | 1,546 |
| Headache | 2,323 | 6.5% | 119 | 578 |
| Anxiety | 2,145 | 6.0% | 26 | 653 |
| Intentional overdose | 2,103 | 5.9% | 438 | 1,642 |
| Drug hypersensitivity | 1,967 | 5.5% | 110 | 71 |
| Seizure | 1,894 | 5.3% | 231 | 1,285 |
| Fatigue | 1,687 | 4.7% | 137 | 203 |
| Nausea | 1,597 | 4.5% | 37 | 459 |
| Product substitution issue | 1,578 | 4.4% | 0 | 25 |
| Off label use | 1,514 | 4.3% | 141 | 410 |
| Drug interaction | 1,443 | 4.1% | 163 | 617 |
Other Indications for BUPROPION
Product used for unknown indication (18,528)
Depression (6,165)
Anxiety (1,145)
Major depression (988)
Suicide attempt (739)
Bipolar disorder (702)
Smoking cessation therapy (702)
Antidepressant therapy (252)
Attention deficit hyperactivity disorder (244)
Ex-tobacco user (205)
Other Drugs Used for Psoriasis
APREMILAST (76,127)
SECUKINUMAB (58,471)
ADALIMUMAB (56,634)
RISANKIZUMAB-RZAA (40,890)
ETANERCEPT (30,483)
USTEKINUMAB (21,763)
IXEKIZUMAB (16,569)
GUSELKUMAB (11,736)
CERTOLIZUMAB PEGOL (8,179)
METHOTREXATE (6,628)